| 000 | 01264 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516185303.0 | ||
| 264 | 0 | _c20140526 | |
| 008 | 201405s 0 0 ger d | ||
| 022 | _a2567-5761 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAumann, V | |
| 245 | 0 | 0 |
_a[Experience with rivaroxaban and dabigatran]. _h[electronic resource] |
| 260 |
_bHamostaseologie _c2013 |
||
| 300 |
_aS61-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAntithrombins _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aDabigatran |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMorpholines _xadministration & dosage |
| 650 | 0 | 4 |
_aProtein C Deficiency _xcomplications |
| 650 | 0 | 4 | _aRivaroxaban |
| 650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_abeta-Alanine _xadministration & dosage |
| 700 | 1 | _aBoxberger, N | |
| 700 | 1 | _aHeim, M U | |
| 700 | 1 | _aHartung, K-J | |
| 700 | 1 | _aSiegemund, A | |
| 773 | 0 |
_tHamostaseologie _gvol. 33 Suppl 1 _gp. S61-3 |
|
| 999 |
_c23373250 _d23373250 |
||